May 25, 2011

Johns Hopkins Medicine and Walgreens on Wednesday announced an agreement between the two companies that will promote collaboration on population-based research.

May 24, 2011

Alterna, a marketer of personal care products and therapeutic over-the-counter medicines, has signed a new trademark and know-how license agreement with Spirig Pharma AG of Egerkingen, Switzerland, which expands Alterna's exclusive rights to distribute Kerasal one-step exfoliating moisturizing foot ointment to 80 countries outside of North America.

May 24, 2011

The American Diabetes Association announced that it will fund research that will examine the effectiveness of technology-based diabetes management devices.

May 24, 2011

The National Association of Chain Drug Stores announced that it submitted on Tuesday a statement to the Senate Subcommittee on Crime and Terrorism for the "Responding to the Prescription Drug Epidemic: Strategies for Reducing Abuse, Misuse, Diversion and Fraud" hearing.

May 24, 2011

CVS Caremark outlined on Tuesday at a consumer health engagement conference the results of a personalized consumer communications program designed to encourage patients to take their medications as doctors direct.

May 24, 2011

Cuts to the Food and Drug Administration could be in the works, according to a published report.

May 24, 2011

Women that experience body mass index gains between their first and second pregnancies are at an increased risk of developing gestational diabetes in the second pregnancy, according to a Kaiser Permanente study.

May 24, 2011

Reps. Aaron Schock, R-Ill., and Peter Welch, D-Vt., on Monday introduced legislation that would exempt community pharmacies with less than 10 locations from having to participate in Medicare competitive acquisition programs and pricing when it comes to the sale of blood-glucose meters and supplies.

May 24, 2011

Drug maker Eli Lilly is partnering with two private investor groups to form a new biotech company based in central Indiana, the company said Monday.

May 24, 2011

California-based companies are developing nearly more than one-fifth of the drugs to treat some of the deadliest diseases in the world, according to an analysis by the drug industry lobby.

May 24, 2011

Several states are cutting funding to programs that provide HIV medications to people who can’t afford them in an effort to reduce spending, according to a published report.

May 24, 2011

Ragweed and mold are driving increased allergies across America, Quest Diagnostics reported Monday.

May 24, 2011

A drug made by Daiichi-Sankyo was safe and effective in maintaining reductions in blood pressure in older patients, according to a new study presented at the American Society of Hypertension’s 26th annual meeting in New York.

May 23, 2011

A generic drug maker has been granted approval from the Food and Drug Administration to manufacture its version of a urinary tract infection treatment.

May 23, 2011

Bayer has launched a reformulated aspirin called Bayer Advanced Aspirin that works in less than half the time of the company's regular aspirin, according to published reports.

May 23, 2011

More and more, there is a new niche being carved out of the take-home test kits being offered through pharmacy. It used to be only pregnancy and ovulation test kits that were available in that space. Now there is a plethora of offerings, including tests for drug abuse, screenings for such conditions as high cholesterol, paternity tests and tests for sexually transmitted diseases.

May 23, 2011

The Food and Drug Administration has approved a treatment for hepatitis C made by Vertex Pharmaceuticals, the agency said Monday.

May 23, 2011

The Food and Drug Administration has approved a generic drug for epilepsy made by Mylan.

May 23, 2011

Church & Dwight in April launched the First Response Digital Ovulation Test, a new at-home ovulation test that can detect a woman’s personal luteinizing hormone surge — the hormonal indication of ovulation — based on her own individual hormone levels.

May 23, 2011

Generic drug maker Par has inked a definitive agreement to acquire an India-based developer and manufacturer of generic drugs.

May 23, 2011

The $290 billion that poor medication adherence costs the U.S. economy every year cuts across every imaginable disease state, but one in which it can be particularly problematic is mental health.


May 23, 2011


It’s not often a niche brand manufacturer attempts to resuscitate what has been for years a commoditized category. But that’s exactly what Meda Consumer Healthcare will be attempting to do with iron — establish a good/better/best proposition to a supplemented category best defined as mediocre.

May 23, 2011

The FDA has approved a new treatment for Type 2 diabetes, the agency said. The FDA announced the approval of Tradjenta (linagliptin) made by Indianapolis-based Eli Lilly and German drug maker Boehringer Ingelheim.


May 23, 2011

Members of a local coalition in Providence, R.I., launched on Monday the Script Your Future campaign, which is part of a national effort to educate consumers on the importance of medication adherence.